KBKeith A. Baggerly

Keith A. Baggerly

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Keith A. Baggerly has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Aysegul A. Sahin

    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    1 shared publication
  • C. Marcelo Aldaz

    Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, USA

    1 shared publication
  • Cintia Notcovich

    Department of Carcinogenesis, The University of Texas MD Anderson Cancer Center, Science Park – Research Division, Smithville, Texas, USA

    1 shared publication
  • David N. Stivers

    Department of Biostatistics, University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030; Cancer Genomics Program, University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030

    1 shared publication
  • Hongxia Sun

    Department of Carcinogenesis, The University of Texas MD Anderson Cancer Center, Science Park – Research Division, Smithville, Texas, USA

    1 shared publication
  • Jeffrey A Drake

    Department of Carcinogenesis, The University of Texas MD Anderson Cancer Center, Science Park – Research Division, Smithville, Texas, USA

    1 shared publication

Latest Publications

  • Open Access

    Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression

    by Martin C Abba, Jeffrey A Drake, Kathleen A Hawkins, Yuhui Hu, Hongxia Sun, Cintia Notcovich, Sally Gaddis, Aysegul Sahin, Keith Baggerly, C Marcelo Aldaz

    Genomic and transcriptomic alterations affecting key cellular processes such us cell proliferation, differentiation and genomic stability are considered crucial for the development and progression of cancer. Most invasive breast carcinomas are known to derive from precursor in situ lesions. It is proposed that major global expression abnormalities occur in the transition from normal to premalignant stages and further progression to invasive stages. Serial analysis of gene expression (SAGE) was employed to generate a comprehensive global gene expression profile of the major changes occurring during breast cancer malignant evolution. In the present study we combined various normal and tumor SAGE libraries available in the public domain with sets of breast cancer SAGE libraries recently generated and sequenced in our laboratory. A recently developed modified t test was used to detect the genes differentially expressed. We accumulated a total of approximately 1.7 million breast tissue-specific SAGE tags and monitored the behavior of more than 25,157 genes during early breast carcinogenesis. We detected 52 transcripts commonly deregulated across the board when comparing normal tissue with ductal carcinoma in situ, and 149 transcripts when comparing ductal carcinoma in situ with invasive ductal carcinoma (P < 0.01). A major novelty of our study was the use of a statistical method that correctly accounts for the intra-SAGE and inter-SAGE library sources of variation. The most useful result of applying this modified t statistics beta binomial test is the identification of genes and gene families commonly deregulated across samples within each specific stage in the transition from normal to preinvasive and invasive stages of breast cancer development. Most of the gene expression abnormalities detected at the in situ stage were related to specific genes in charge of regulating the proper homeostasis between cell death and cell proliferation. The comparison of in situ lesions with fully invasive lesions, a much more heterogeneous group, clearly identified as the most importantly deregulated group of transcripts those encoding for various families of proteins in charge of extracellular matrix remodeling, invasion and cell motility functions.


  • Identifying Differentially Expressed Genes in cDNA Microarray Experiments

    by Keith A. Baggerly, Kevin R. Coombes, Kenneth R. Hess, David N. Stivers, Lynne V. Abruzzo, Wei Zhang

    A major goal of microarray experiments is to determine which genes are differentially expressed between samples. Differential expression has been assessed by taking ratios of expression levels of different samples at a spot on the array and flagging spots (genes) where the magnitude of the fold difference exceeds some threshold. More recent work has attempted to incorporate the fact that the variability of these ratios is not constant. Most methods are variants of Student's t-test. These variants standardize the ratios by dividing by an estimate of the standard deviation of that ratio; spots with large standardized values are flagged. Estimating these standard deviations requires replication of the measurements, either within a slide or between slides, or the use of a model describing what the standard deviation should be. Starting from considerations of the kinetics driving microarray hybridization, we derive models for the intensity of a replicated spot, when replication is performed within and between arrays. Replication within slides leads to a beta-binomial model, and replication between slides leads to a gamma-Poisson model. These models predict how the variance of a log ratio changes with the total intensity of the signal at the spot, independent of the identity of the gene. Ratios for genes with a small amount of total signal are highly variable, whereas ratios for genes with a large amount of total signal are fairly stable. Log ratios are scaled by the standard deviations given by these functions, giving model-based versions of Studentization. An example is given.